New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
|Slideshows|April 16, 2018
3 New Updates on Pediatric Bipolar Disorder
Author(s)Mark L. Fuerst
This report includes a study on patterns of prodromal psychiatric symptoms that may help identify young persons at increased risk of bipolar disorder; sibling bullying and risk of psychotic disorders; and a new smartphone app that tracks moods and predicts bipolar disorder episodes.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
2
Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD
3
The Silence Between the Questions: Reflections on Adolescent Suicide Risk When Intent Is Unclear
4
New Adult ADHD Guidelines: What Resources Are Coming Soon
5